Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.

Real-time index price for TSX Utilities Capped Index (TTUT), along with buy or sell indicators, analysis, charts, historical ...

Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...

A review in Biomolecules and Biomedicine sheds light on how microRNAs (miRNAs)—small regulatory RNA molecules—play a central ...

Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...

A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...

Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...

An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...

Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...

Abstract Extracorporeal hemoadsorption for treating bacteremia has exhibited limited success due to the lack of a clear strategy for effectively ...

Recce Pharmaceuticals (ASX:RCE) said it had received a notice of acceptance from the China National Intellectual Property ...